John G Ullman & Associates Inc Merck & Co., Inc. Transaction History

John G Ullman & Associates Inc

  • $649 Million
  • Q3 2024

A detailed history of John G Ullman & Associates Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, John G Ullman & Associates Inc holds 97,472 shares of MRK stock, worth $9.42 Million. This represents 1.71% of its overall portfolio holdings.

Number of Shares
97,472
Previous 97,471 -0.0%
Holding current value
$9.42 Million
Previous $12.1 Million 8.27%
% of portfolio
1.71%
Previous 1.91%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
BUY
$111.15 - $128.97 $10.8 Million - $12.6 Million
97,472 New
97,472 $11.1 Million
Q2 2024

Aug 08, 2024
SELL
$123.8 - $132.96 $90,126 - $96,794
-728 Reduced 0.74%
97,471 $12.1 Million
Q1 2024

May 06, 2024
SELL
$113.24 - $131.95 $67,944 - $79,170
-600 Reduced 0.61%
98,199 $13 Million
Q4 2023

Jan 31, 2024
SELL
$100.18 - $109.02 $107,192 - $116,651
-1,070 Reduced 1.07%
98,799 $10.8 Million
Q3 2023

Nov 01, 2023
SELL
$102.95 - $114.33 $97,802 - $108,613
-950 Reduced 0.94%
99,869 $10.3 Million
Q2 2023

Aug 21, 2023
SELL
$108.61 - $118.38 $94,707 - $103,227
-872 Reduced 0.86%
100,819 $11.6 Million
Q1 2023

May 05, 2023
SELL
$102.94 - $114.86 $68,249 - $76,152
-663 Reduced 0.65%
101,691 $10.8 Million
Q4 2022

Feb 08, 2023
SELL
$87.44 - $112.11 $2.72 Million - $3.49 Million
-31,118 Reduced 23.31%
102,354 $11.4 Million
Q3 2022

Oct 19, 2022
SELL
$84.53 - $94.96 $122,314 - $137,407
-1,447 Reduced 1.07%
133,472 $11.5 Million
Q2 2022

Jul 27, 2022
BUY
$83.49 - $94.64 $2,671 - $3,028
32 Added 0.02%
134,919 $12.3 Million
Q1 2022

Apr 29, 2022
BUY
$73.51 - $82.4 $7,645 - $8,569
104 Added 0.08%
134,887 $11.1 Million
Q4 2021

Jan 26, 2022
BUY
$72.28 - $90.54 $524,752 - $657,320
7,260 Added 5.69%
134,783 $10.3 Million
Q3 2021

Nov 02, 2021
BUY
$71.68 - $78.83 $3.45 Million - $3.79 Million
48,100 Added 60.56%
127,523 $9.58 Million
Q2 2021

Jul 23, 2021
SELL
$70.31 - $77.77 $35,155 - $38,885
-500 Reduced 0.63%
79,423 $6.18 Million
Q1 2021

Apr 22, 2021
SELL
$68.86 - $81.11 $61,974 - $72,999
-900 Reduced 1.11%
79,923 $6.16 Million
Q4 2020

Feb 05, 2021
SELL
$71.77 - $79.65 $41,841 - $46,435
-583 Reduced 0.72%
80,823 $6.61 Million
Q3 2020

Nov 06, 2020
SELL
$73.18 - $82.95 $9,732 - $11,032
-133 Reduced 0.16%
81,406 $6.75 Million
Q2 2020

Jul 29, 2020
SELL
$70.42 - $80.13 $26,970 - $30,689
-383 Reduced 0.47%
81,539 $6.31 Million
Q1 2020

Apr 14, 2020
SELL
$63.36 - $87.82 $9,123 - $12,646
-144 Reduced 0.18%
81,922 $6.3 Million
Q4 2019

Jan 29, 2020
SELL
$77.58 - $87.54 $155,160 - $175,080
-2,000 Reduced 2.38%
82,066 $7.46 Million
Q3 2019

Oct 21, 2019
SELL
$76.08 - $82.93 $122,412 - $133,434
-1,609 Reduced 1.88%
84,066 $7.08 Million
Q2 2019

Aug 02, 2019
SELL
$69.84 - $81.59 $3.8 Million - $4.44 Million
-54,400 Reduced 38.84%
85,675 $7.18 Million
Q1 2019

Apr 30, 2019
SELL
$69.58 - $79.36 $3.96 Million - $4.52 Million
-56,936 Reduced 28.9%
140,075 $11.7 Million
Q4 2018

Jan 29, 2019
SELL
$65.24 - $75.71 $3.49 Million - $4.05 Million
-53,452 Reduced 21.34%
197,011 $15.1 Million
Q3 2018

Nov 02, 2018
SELL
$57.69 - $67.84 $63,459 - $74,624
-1,100 Reduced 0.44%
250,463 $17.8 Million
Q2 2018

Jul 23, 2018
BUY
$50.83 - $59.72 $644,321 - $757,010
12,676 Added 5.31%
251,563 $15.3 Million
Q1 2018

Apr 19, 2018
BUY
$50.96 - $59.23 $1.77 Million - $2.06 Million
34,719 Added 17.01%
238,887 $13 Million
Q4 2017

Jan 31, 2018
SELL
$51.62 - $61.64 $154,911 - $184,981
-3,001 Reduced 1.45%
204,168 $11.5 Million
Q3 2017

Nov 03, 2017
BUY
$58.67 - $63.13 $12.2 Million - $13.1 Million
207,169
207,169 $13.3 Million

Others Institutions Holding MRK

# of Institutions
3,815
Shares Held
1.87B
Call Options Held
15.6M
Put Options Held
13.7M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $245B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track John G Ullman & Associates Inc Portfolio

Follow John G Ullman & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of John G Ullman & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on John G Ullman & Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email